Isoprenoid Precursor Production via Simplified Phosphorylation Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Isoprenoids are difficult to extract and purify in sufficient quantities due to their natural scarcity and the complexity and costliness of chemical synthesis, and existing biosynthetic pathways are limited by length, complex regulation, and extensive cofactor requirements.
Innovation Solution
A novel Isopentenol Utilization Pathway (IUP) that phosphorylates isopentenol or prenol to produce isopentenyl diphosphate or dimethylallyl diphosphate, the main precursors for isoprenoid synthesis, using recombinantly expressed enzymes such as choline kinase and isopentenyl phosphate kinase, allowing for efficient production of isoprenoid precursors and isoprenoids in engineered cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If natural isoprenoid pathways (MVA or MEP) are used, then isoprenoid precursors can be produced through central carbon metabolism, but the pathways are limited by their length, complex regulation, and extensive cofactor requirements
Solution Approach 1:
The patent segments the complex natural isoprenoid pathways into a simplified two-step synthetic pathway. Instead of using the entire MVA or MEP pathway with multiple enzymes and cofactors, the invention isolates and optimizes only the critical phosphorylation steps (isoprenol → isopentenyl phosphate → isopentenyl diphosphate), eliminating unnecessary complexity while maintaining productivity.
Solution Approach 2:
The patent extracts the essential functional steps from the complex natural pathways. By taking out only the phosphorylation reactions catalyzed by specific kinases (overcoming the limitation of extensive cofactor requirements through substrate-level phosphorylation), the invention creates a streamlined pathway that bypasses the regulatory complexity of central carbon metabolism.
2Ease of manufacture
If existing biosynthetic pathways are used, then isoprenoid precursors can be produced, but the pathways suffer from extensive cofactor requirements and complex regulation
Solution Approach 1:
The patent implements self-service by using substrate-level phosphorylation where the substrate itself (isoprenol or prenol) provides the phosphate group through direct phosphorylation by kinases using ATP, eliminating the need for extensive additional cofactors. The pathway essentially serves itself by using the simplest possible energy carrier (ATP) without requiring the complex cofactor regenerating systems needed in natural pathways.
3Productivity
If natural pathways are used, then isoprenoid precursors can be produced through central carbon metabolism, but there is competition with central carbon metabolism for resources
Solution Approach 1:
The patent extracts the isoprenoid precursor production function from central carbon metabolism by using isoprenol or prenol as direct substrates. This extraction creates pathway independence, allowing high-flux precursor production without competing with other central metabolic processes for carbon and energy resources.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The IUP pathway overcomes the limitations of natural pathways by simplifying the process to two steps with a single cofactor (ATP), reducing competition with central carbon metabolism, and achieving isoprenoid precursor production comparable to high-reported fluxes, demonstrating improved efficiency and scalability.
Implementation Method 1
choline kinase catalyzing the phosphorylation of isoprenol to produce isopentenyl monophosphate
Implementation Method 2
isopentenyl phosphate kinase catalyzing the phosphorylation of isopentenyl monophosphate to produce isopentenyl diphosphate
Data Source
AI summary
Disclosed herein are engineered cells and cell-free systems, compositions, and methods for conversion of isopentenols to isoprenoid precursors.